The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Effectiveness of dienogest in improving quality of life in Asian women with endometriosis (ENVISIOeN): interim results from a prospective cohort study under real-life clinical practice
Open accessAbstract
BACKGROUND: Dienogest has been shown to substantially improve endometriosis-associated symptoms such as debilitating chronic pelvic pain, and in turn, health-related quality of life (HRQoL). To date, there is no data on patient-reported outcomes reflecting the real-world practice in Asia where endometriosis is a relevant health, social and economic burden. This non-interventional, multi-center, prospective study aims to investigate the influence of dienogest on HRQoL. METHODS: Asian women received dienogest (2 mg/daily) and were followed for 24 months. The effectiveness of dienogest to improve HRQoL and endometriosis-associated pelvic pain (EAPP) was assessed by patient-reported outcomes. HRQoL, especially the "pain" domain as primary endpoint, was evaluated with the Endometriosis Health Profile-30 (EHP-30) questionnaire. The numeric rating scale served to determine changes in the severity of EAPP. Within the presented interim analysis (data cut-off: 2017-11-27), the mean changes in EHP-30 and EAPP scores from baseline to 6 months upon availability of the data were evaluated. Treatment-emergent adverse events (TEAEs) and bleeding profiles were documented. RESULTS: Dienogest therapy decreased EHP-30 scores in all assessed domains (score 0-100, lower scores indicate better HRQoL). Primarily, the "pain" domain was improved in 78.4% of patients. EAPP was reduced (score 0-10, lower scores reflect less pain), highlighted by a mean reduction of the pain score by - 4.5 points. Patients with a higher EAPP score at baseline had an increased response to dienogest (- 6.2 points mean change) compared to patients with low baseline EAPP severity (- 1.4 points mean change). Both surgically and clinically diagnosed patients described comparable pain reduction, as well as women with or without prior treatment. Drug-related TEAEs were documented for 31.5% of patients, with amenorrhoea (5.9%) and metrorrhagia (5.1%) being the most common events. The bleeding pattern was changed upon dienogest, characterized by decreased normal bleeding (84.2 to 28.8%) and increased amenorrhea (3.2 to 42.9%) at 6 months. CONCLUSION: The data indicate an amelioration of HRQoL and EAPP upon dienogest therapy. No new safety signals were observed. Therefore, its use as first-line therapy for long-term management of debilitating and chronic endometriosis-associated pain represents an interesting option that remains to be further investigated. TRIAL REGISTRATION: Name of registry: Clinical Trials Clinicaltrials.gov registration number: NCT02425462 Registration date: 2015-04-24. Registration timing: prospective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Both surgically and clinically diagnosed patients described comparable pain reduction, as well as women with or without prior treatment [187].”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [187]
The cited source says what the claim attributes to it.
In the citing paper
“Patients treated with DNG have also shown an improvement of sexual functioning [194] and QoL [187, 199].”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [187]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Among Asian women, DNG therapy decreased Endometriosis Health Profile-30 (EHP-30) scores in all assessed domains, especially the”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [200]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ESHRE guideline: management of women with endometriosis
Dunselman, G. A. J., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D'Hooghe, T., De Bie, B., Heikinheimo, O., Horne, A. W., Kiesel, L., Nap, A., et al. (2014) · Human Reproduction · doi:10.1093/humrep/det457 · Cited by 2,211
ESHRE guideline for the diagnosis and treatment of endometriosis
Kennedy, S., Bergqvist, A., Chapron, C., D’Hooghe, T., Dunselman, G., Greb, R., Hummelshoj, L., Prentice, A., & Saridogan, E. (2005) · Human Reproduction · doi:10.1093/humrep/dei135 · Cited by 1,584
Recurrence of endometriosis and its control
Guo, S.-W. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp007 · Cited by 719
World Endometriosis Society consensus on the classification of endometriosis
Johnson, N. P., Hummelshoj, L., Adamson, G. D., Keckstein, J., Taylor, H. S., Abrao, M. S., Bush, D., Kiesel, L., Tamimi, R., Sharpe-Timms, K. L., et al. (2017) · Human Reproduction · doi:10.1093/humrep/dew293 · Cited by 664
Consensus on current management of endometriosis
Johnson, N. P., Hummelshoj, L., for the World Endometriosis Society Montpellier Consortium, Abrao, M. S., Adamson, G. D., Allaire, C., Amelung, V., Andersson, E., Becker, C., Birna Árdal, K. B., et al. (2013) · Human Reproduction · doi:10.1093/humrep/det050 · Cited by 558
Development of an endometriosis quality-of-life instrument: The Endometriosis Health Profile-30
Jones, G. (2001) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(01)01433-8 · Cited by 334
Epidemiology of endometriosis among parous women
SANGIHAGHPEYKAR, H., & POINDEXTERIII, A. (1995) · Obstetrics & Gynecology · doi:10.1016/0029-7844(95)00074-2 · Cited by 288
Strowitzki, T., Faustmann, T., Gerlinger, C., & Seitz, C. (2010) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2010.04.002 · Cited by 227
Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment
Petraglia, F., Hornung, D., Seitz, C., Faustmann, T., Gerlinger, C., Luisi, S., Lazzeri, L., & Strowitzki, T. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-1941-7 · Cited by 200
Köhler, G., Faustmann, T. A., Gerlinger, C., Seitz, C., & Mueck, A. O. (2010) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2009.08.020 · Cited by 159
Cited by
Hormonal treatments for endometriosis: The endocrine background
Vannuccini, S., Clemenza, S., Rossi, M., & Petraglia, F. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09666-w · Cited by 336
Zakhari, A., Edwards, D., Ryu, M., Matelski, J. J., Bougie, O., & Murji, A. (2020) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2020.05.007 · Cited by 86
Barra, F., Scala, C., Maggiore, U. L. R., & Ferrero, S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010154 · Cited by 61
Piacenti, I., Viscardi, M. F., Masciullo, L., Sangiuliano, C., Scaramuzzino, S., Piccioni, M. G., Muzii, L., Panici, P. B., & Porpora, M. G. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1892632 · Cited by 52
Understanding Psychological Symptoms of Endometriosis from a Research Domain Criteria Perspective
van Stein, K., Schubert, K., Ditzen, B., & Weise, C. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12124056 · Cited by 40
Metadata
- Authors
- Techatraisak, K., Hestiantoro, A., Ruey, S., Banal-Silao, M. J., Kim, M.-R., Seong, S. J., Thaufik, S., Ahlers, C., Shin, S. Y., & Lee, B. S.
- Affiliations
- Siriraj Hospital (TH)
- Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo (ID)
- Philippine General Hospital (PH)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- CHA University (KR)
- Bayer (Germany) (DE)
- Yonsei University (KR)
- Corresponding author
- Lee, Byung Seok
- Venue
- BMC Women's Health
- Published
- 2019-05-16
- Volume
- 19
- Issue
- 1
- Pages
- 68-68
- ISSN
- 1472-6874 (ISSN-L)
- PMC
- PMC6524261
- OpenAlex
- W2947876135
- Cited by
- 36
- References
- 24
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 1 · 2023: 5 · 2022: 6 · 2021: 7 · 2020: 8
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- BMC Women s Health (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- Greater South Information System
- Funders
- Bayer
- Yonsei University
- Catholic University of Korea
- CHA University
- Seoul St. Mary's Hospital, Catholic University of Korea
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Keywords
- dienogest, endometriosis, health-related quality of life, patient-reported outcomes, Asian women, treatment-emergent adverse events, amenorrhea, metrorrhagia, bleeding patterns, real-world effectiveness, chronic pelvic pain, progestin therapy
- MeSH terms
- Adult, Endometriosis, Female, Hormone Antagonists, Humans, Middle Aged, Nandrolone, Prospective Studies, Quality of Life, Severity of Illness Index, Cohort Studies, Treatment Outcome, Pelvic Pain, Asian People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effectiveness of dienogest in improving quality of life in Asian women with endometriosis (ENVISIOeN): interim results from a prospective cohort study under real-life clinical practice. https://app.cochat.ai/papers/10.1186/s12905-019-0758-6
- The paper
- Techatraisak, K., Hestiantoro, A., Ruey, S., Banal-Silao, M. J., Kim, M.-R., Seong, S. J., Thaufik, S., Ahlers, C., Shin, S. Y., & Lee, B. S. (2019). Effectiveness of dienogest in improving quality of life in Asian women with endometriosis (ENVISIOeN): interim results from a prospective cohort study under real-life clinical practice. BMC Women's Health. https://doi.org/10.1186/s12905-019-0758-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.